These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12942933)

  • 1. [Pharmacoeconomical aspects of the use of beta-blockers in hypertension and heart failure].
    Ostroumova OD; Mamaev VI; Ishchenko KA; Shorikova EG
    Kardiologiia; 2003; 43(5):87-96. PubMed ID: 12942933
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmaco-economic aspects of the treatment of hypertension].
    Delporte JP; Rorive G
    Rev Med Liege; 1998 May; 53(5):259-64. PubMed ID: 9689879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of hypertension treatment in Sweden: an analysis of the criteria for intervention and the choice of drug treatment.
    Johannesson M
    J Hum Hypertens; 1996 Feb; 10 Suppl 2():S23-6. PubMed ID: 8868040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost-effectiveness of the switch towards more expensive antihypertensive drugs.
    Johannesson M
    Health Policy; 1994 Mar; 28(1):1-13. PubMed ID: 10136603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).
    Reed SD; Friedman JY; Velazquez EJ; Gnanasakthy A; Califf RM; Schulman KA
    Am Heart J; 2004 Jul; 148(1):122-8. PubMed ID: 15215801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertensive medication and erectile dysfunction.
    Hackett G
    Cardiovasc Ther; 2010; 28(1):5-7. PubMed ID: 20074253
    [No Abstract]   [Full Text] [Related]  

  • 9. Following evidence-based prescribing guidelines for antihypertensives could save big bucks.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Jun; 15(11):1, 6-7. PubMed ID: 15241883
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacoeconomics of beta-blockers: effective and cost-effective therapy in chronic heart failure.
    Krum H; Lim S
    Eur J Heart Fail; 2001 Aug; 3(4):399-402. PubMed ID: 11511423
    [No Abstract]   [Full Text] [Related]  

  • 11. [Medical economics of hypertension therapy].
    Yamazaki T
    Nihon Rinsho; 2008 Aug; 66(8):1601-4. PubMed ID: 18700564
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta-blockers and the treatment of hypertension.
    Williams B
    J Hypertens; 2007 Jul; 25(7):1351-3. PubMed ID: 17563554
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cost-effectiveness of treatment of high blood pressure with losartan in Denmark].
    Keiding H; Hildebrandt P; Burke T; Carides GW
    Ugeskr Laeger; 2006 Oct; 168(42):3623-6. PubMed ID: 17069726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy for hypertension associated with heart failure].
    Miyamoto H; Imaizumi T
    Nihon Naika Gakkai Zasshi; 2003 Feb; 92(2):258-63. PubMed ID: 12652730
    [No Abstract]   [Full Text] [Related]  

  • 15. [Alpha beta-blockers for patients with hypertension].
    Mizuta Y; Imaizumi T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():305-9. PubMed ID: 16981560
    [No Abstract]   [Full Text] [Related]  

  • 16. Will beta-blockers save money?
    Heidenreich PA
    J Card Fail; 2005 Dec; 11(9):657-8. PubMed ID: 16360959
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacoeconomics of hypertension control: basic principles of economic evaluation.
    Wilson TW; Chockalingam A; Quest DW
    J Hum Hypertens; 1996 Feb; 10 Suppl 2():S19-22. PubMed ID: 8868039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypertension in patients with heart failure].
    Takekoshi N; Asaji T; Tada N
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():478-83. PubMed ID: 15171419
    [No Abstract]   [Full Text] [Related]  

  • 19. Mild-to-moderate uncomplicated hypertension: further analysis of a cost-effectiveness study of five drugs.
    Richter A; Gondek K; Ostrowski C; Dombeck M; Lamb S
    Manag Care Interface; 2001 Jul; 14(7):61-9. PubMed ID: 11481819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective versus nonselective beta adrenoceptor antagonists in hypertension.
    Van Bortel LM; Ament AJ
    Pharmacoeconomics; 1995 Dec; 8(6):513-23. PubMed ID: 10160080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.